MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health Cash and Cash Equivalents 2011-2026 | OPK
Annual Cash and Cash Equivalents OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 427 M | 95.9 M | 153 M | 135 M | 72.2 M | 85.5 M | 96.5 M | 91.5 M | 169 M | 194 M | 96.9 M | 186 M | 27.4 M | 71.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 427 M | 27.4 M | 136 M |
Quarterly Cash and Cash Equivalents OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 267 M | 429 M | 400 M | 40.6 M | 75.6 M | 139 M | 108 M | 111 M | 153 M | 181 M | 210 M | 102 M | 135 M | 149 M | 65.8 M | 89.5 M | 72.2 M | 72.2 M | 72.2 M | 72.2 M | 85.5 M | 85.5 M | 85.5 M | 85.5 M | 96.5 M | 96.5 M | 96.5 M | 96.5 M | 91.5 M | 91.5 M | 91.5 M | 91.5 M | 169 M | 169 M | 169 M | 169 M | 194 M | 194 M | 194 M | 194 M | 96.9 M | 96.9 M | 96.9 M | 96.9 M | 186 M | 186 M | 186 M | 186 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 71.5 M | 71.5 M | 71.5 M | 71.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 429 M | 27.4 M | 125 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Lantheus Holdings
LNTH
|
359 M | $ 74.6 | -1.49 % | $ 5.03 B |  USA |
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
51.2 M | $ 9.28 | 3.11 % | $ 618 M | USA |
|
Biodesix
BDSX
|
26.2 M | $ 15.5 | 5.51 % | $ 2.01 B | USA |
 |
Medpace Holdings
MEDP
|
497 M | $ 465.57 | 1.89 % | $ 13.4 B | USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M |  Israel |
 |
Myriad Genetics
MYGN
|
150 M | $ 4.7 | 0.86 % | $ 435 M | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 17.38 | -0.77 % | $ 389 M | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
13.3 M | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
14.9 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
Pacific Biosciences of California
PACB
|
63.7 M | $ 1.39 | - | $ 417 M | USA |
 |
Charles River Laboratories International
CRL
|
214 M | $ 160.55 | 1.56 % | $ 7.96 B | USA |
 |
IQVIA Holdings
IQV
|
1.98 B | $ 168.36 | 0.81 % | $ 28.9 B | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
2.99 M | $ 1.21 | -17.22 % | $ 6.59 M | USA |
 |
Mettler-Toledo International
MTD
|
66.9 M | $ 1 268.55 | 2.27 % | $ 26.1 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
1.46 M | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
1.13 B | $ 126.25 | 1.99 % | $ 20.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
1.5 M | $ 27.01 | 0.3 % | $ 35.1 M | USA |
 |
Personalis
PSNL
|
91.4 M | $ 7.73 | 1.58 % | $ 458 M | USA |
 |
RadNet
RDNT
|
767 M | $ 59.61 | -3.45 % | $ 4.48 B | USA |
 |
Celcuity
CELC
|
22.5 M | $ 101.54 | -4.89 % | $ 4.01 B | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 266.82 | 0.88 % | $ 22.2 B | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 6.74 | 1.81 % | $ 281 M | USA |
 |
Sotera Health Company
SHC
|
345 M | $ 13.89 | 0.07 % | $ 3.94 B | USA |
 |
ENDRA Life Sciences
NDRA
|
3.23 M | $ 3.49 | 0.29 % | $ 1.87 M | USA |
 |
NeoGenomics
NEO
|
160 M | $ 7.94 | -1.98 % | $ 1.02 B | USA |
 |
Soleno Therapeutics
SLNO
|
70.1 M | $ 30.98 | -2.33 % | $ 1.57 B | USA |
 |
Natera
NTRA
|
466 M | $ 197.02 | -1.53 % | $ 19.4 B | USA |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 17.95 | 2.22 % | $ 957 M | USA |
 |
Neuronetics
STIM
|
28.1 M | $ 1.49 | -6.88 % | $ 98.3 M | USA |
 |
Castle Biosciences
CSTL
|
120 M | $ 25.59 | -0.62 % | $ 711 M | USA |
 |
DarioHealth Corp.
DRIO
|
21.8 M | $ 7.99 | 6.53 % | $ 31.8 M | Israel |
 |
DexCom
DXCM
|
918 M | $ 66.84 | 1.36 % | $ 26.1 B | USA |
 |
Exact Sciences Corporation
EXAS
|
956 M | $ 104.91 | - | $ 19.8 B | USA |